EFFECT OF DRY NEEDLING ON DELAYED ONSET MUSCLE SORENES IN HEALTHY WOMEN: A RANDOMIZED, BLINDED, CONTROLLED TRIAL
dry needling, delayed onset muscle soreness, physical exercise.
Introduction: High-performance athletes, as well as individuals who engage in physical activity, are likely to experience Delayed Onset Muscle Soreness (DOMS) at some point, possibly due to unfamiliar exercises or excessive repetitions or loads. Strategies to accelerate recovery should be implemented to help individuals return to performing exercises efficiently as quickly as possible. In the scientific community, the use of Dry Needling (DN) has been gaining attention, although its effects on DOMS are still not well-studied. Objective: To investigate the effect of DN on DOMS administered immediately after an eccentric exercise protocol on the biceps brachii in healthy women. Methods: This is a controlled, randomized, and blinded clinical trial composed of forty women. Initially, all participants underwent an evaluation consisting of pain sensation measurement (using the numerical pain scale and algometry), dynamometry, and treatment expectations. The participants then performed a protocol of eccentric exercises on an isokinetic dynamometer, consisting of 2 sets of 6 eccentric contractions at 60°/s for elbow flexors. After completing the protocol, an intervention was performed according to the group that was previously and randomly assigned: DN group, where participants received dry needling, and a sham group (SG) with simulated needle penetration. Finally, participants were re-evaluated immediately and 48 hours after the intervention protocol, except for the Numerical Pain Scale (NPS), which was also evaluated 24 and 72 hours after exercise. Pain sensation (NPS and pain threshold), peak torque normalized by body weight, average peak torque, power, and work were analyzed. For statistical analysis, the Kolmogorov-Smirnov and Levene tests were used, followed by mixed ANOVA. The Bonferroni post-hoc test was applied to identify differences when a significant F-value was found. Statistical significance was set at 5%, with a 95% confidence interval. Results: No significant differences were observed between the groups for pain sensation at any time point. No differences were found between the groups for the other secondary outcomes. Conclusion: The treatment with DN was not superior to sham in reducing pain sensation, pain threshold, or muscle performance in the participants.